Brief: Kane Biotech says private placement offering of up to 66.7 mln units
27/01/2016 13:00
Jan 27 (Reuters) - Kane Biotech Inc KNE.V : * Announces private placement offering * Intention of the company to undertake a non-brokered private placement offering of up to 66.7 million units at $0.06 per unit * Net proceeds of offering will be used for investing in revenue growth through commercialization of co's extensive patent portfolio * Source text for Eikon ID:nMKWWMYcYa * Further company coverage KNE.V ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update